CervoMed Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
CervoMed Inc. (CRVO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $39.73 thousand as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2021-11-10
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $39.73K.
- 2021-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $39.73K.
- 2021-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $39.73K.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $118.52K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2021-09-30 | $39.73K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $39.73K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $39.73K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $118.52K 10-K · filed 2021-03-17 |
| 2020-09-30 | $118.52K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $118.52K 10-Q · filed 2020-08-07 |
| 2019-12-31 | $116.46K 10-K · filed 2020-03-17 |
| 2018-12-31 | $114.41K 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |